HEALTHCARE RESOURCE UTILISATION IN MIGRAINE PATIENTS STRATIFIED BY PRIOR PROPHYLACTIC TREATMENT FAILURE, FREQUENCY OF MONTHLY MIGRAINE DAYS AND MEDICATION OVERUSE: EVIDENCE FROM THE BECOME STUDY

被引：0
|
作者：
Gaul, Charly [1 ]
Lucas, Christian [2 ]
Pozo-Rosich, Patricia [3 ,4 ]
Watson, David P. B. [5 ]
Martelletti, Paolo [6 ]
Ritter, Shannon [7 ]
Snellman, Josefin [8 ]
机构：
[1] Migraine & Headache Clin Konigstein, Konigstein, Germany
[2] CHU Lille, Serv Neurochirurg, Pain Clin, Hop Salengro, Lille, France
[3] Vall dHebron Univ Hosp, Dept Neurol, Headache Unit, Barcelona, Spain
[4] Univ Autonoma Barcelona, Headache Res Grp, VHIR, Barcelona, Spain
[5] Hamilton Med Grp, Aberdeen, Scotland
[6] Sapienza Univ Rome, St Andrea Hosp, Dept Clin & Mol Med, Rome, Italy
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Novartis Pharma AG, Basel, Switzerland
来源：
CEPHALALGIA | 2020年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTV20-DP-0
引用
收藏
页码：71 / 73
页数：3
相关论文
共 31 条
  • [21] Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study
    Patricia Pozo-Rosich
    Christian Lucas
    David P. B. Watson
    Charly Gaul
    Emma Ramsden
    Shannon Ritter
    Paolo Martelletti
    Josefin Snellman
    Pain and Therapy, 2021, 10 : 1691 - 1708
  • [22] EFFECT OF ERENUMAB ON PATIENT-REPORTED OUTCOMES IN EPISODIC MIGRAINE PATIENTS WITH PRIOR PROPHYLACTIC TREATMENT FAILURE: RESULTS FROM A POST HOC ANALYSIS OF THE STRIVE STUDY
    Pascual, J.
    Buse, D. C.
    Starling, A.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Picard, H.
    Klatt, J.
    Mikol, D. D.
    CEPHALALGIA, 2018, 38 : 47 - 48
  • [23] Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine Patients with Prior Prophylactic Treatment Failure: Results from a Post-Hoc Analysis of the STRIVE study
    Pascual, J.
    Buse, D.
    Starling, A. J.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Picard, H.
    Klatt, J.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 409 - 409
  • [24] Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine Patients with Prior Prophylactic Treatment Failure: Results from a Post-Hoc Analysis of the STRIVE Study
    Pascual, J.
    Buse, D. C.
    Starling, A. J.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Pichard, H.
    Klatt, J.
    Mikol, D.
    HEADACHE, 2018, 58 : 179 - 180
  • [25] Galcanezumab significantly reduced healthcare resource utilisation and acute medication use in patients with chronic migraine: Findings from a Phase 3, placebo-controlled study with open-label extension
    Joshi, S.
    Tobin, J. A.
    Ford, J.
    Nichols, R.
    Foster, S. A.
    Ruff, D. D.
    Detke, H.
    Aurora, S. K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 630 - 630
  • [26] Patient-Reported Outcomes in Chronic Migraine Patients with Prior Prophylactic Treatment Failure Receiving Placebo or Erenumab: Subgroup Analysis of a Pivotal Randomised Study
    Lanteri-Minet, M.
    Buse, D.
    Starling, A. J.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Cheng, S.
    Klatt, J.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 409 - 409
  • [27] Patient-Reported Outcomes in Chronic Migraine Patients with Prior Prophylactic Treatment Failure Receiving Placebo or Erenumab: Subgroup Analysis of a Pivotal Randomized Study
    Lanteri-Minet, M.
    Buse, D. C.
    Starling, A. J.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, S.
    Desai, P.
    Cheng, S.
    Klatt, J.
    Mikol, D.
    HEADACHE, 2018, 58 : 170 - 171
  • [28] PATIENT-REPORTED OUTCOMES IN CHRONIC MIGRAINE PATIENTS WITH PRIOR PROPHYLACTIC TREATMENT FAILURE RECEIVING PLACEBO OR ERENUMAB: SUBGROUP ANALYSIS OF A PIVOTAL RANDOMISED STUDY
    Lanteri-Minet, M.
    Buse, D. C.
    Starling, A.
    Ailani, J.
    Zhang, F.
    Wen, S.
    Bilitou, A.
    Desai, P.
    Cheng, S.
    Klatt, J.
    Mikol, D. D.
    CEPHALALGIA, 2018, 38 : 49 - 50
  • [29] Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study
    Ashina, Messoud
    Tepper, Stewart J.
    Brandes, Jan Lewis
    Reuter, Uwe
    Boudreau, Guy P.
    Dolezil, David
    Cheng, Sunfa
    Leonardi, Dean
    Lenz, Robert A.
    Klatt, Jan
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [30] Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study
    Ashina, M.
    Tepper, S.
    Brandes, J.
    Reuter, U.
    Boudreau, G.
    Dolezil, D.
    Cheng, S.
    Leonardi, D.
    Lenz, R.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 470 - 471
1234